Loading…

AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells

Background and Objectives AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effec...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2012-11, Vol.106 (6), p.680-688
Main Authors: Yang, Weng-Lang, Perillo, William, Liou, Deanna, Marambaud, Philippe, Wang, Ping
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03
cites cdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03
container_end_page 688
container_issue 6
container_start_page 680
container_title Journal of surgical oncology
container_volume 106
creator Yang, Weng-Lang
Perillo, William
Liou, Deanna
Marambaud, Philippe
Wang, Ping
description Background and Objectives AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics. Methods Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting. Results Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C. Conclusions Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.
doi_str_mv 10.1002/jso.23184
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1113980650</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1113980650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</originalsourceid><addsrcrecordid>eNp1kUFv0zAYhi0EYmVw4A8gS1zGIdtnO7Hj41SxDugYCBBHy3Vs6pLEwU609cZPx223HZB2-mR9z_vos16EXhM4JQD0bJPCKWWkLp-gGQHJCwmyfopmeUeLUkg4Qi9S2gCAlLx8jo4o5aLklM_Q3_OrL5-w79d-5ccQsQndEKa-wXOcpmGINiWbsLFti4cYWu9s1KMPPV5tc6qZzP4RHNZDGMaQfMI6p_U0hmGtf-0gvJ463WdzG6I1o26x0b2xcW9NL9Ezp9tkX93NY_Tj4v33-WWxvF58mJ8vC8MkKQsnDC1rTWqnOa0bTkzpHOiGSFpZ5ogg1q6McU4DB1tCXToKgtuKAdRVA-wYnRy8-Rt_JptG1fm0u0D3NkxJEUKYrIFXO_Ttf-gmTLHP1ylSVVSAJBXL1LsDZWJIKVqnhug7HbeKgNrVonItal9LZt_cGadVZ5sH8r6HDJwdgBvf2u3jJvXx2_W9sjgkfBrt7UNCx9-KCyYq9fPzQi0vxUKwr1Qt2T8I06c0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1552709153</pqid></control><display><type>article</type><title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Yang, Weng-Lang ; Perillo, William ; Liou, Deanna ; Marambaud, Philippe ; Wang, Ping</creator><creatorcontrib>Yang, Weng-Lang ; Perillo, William ; Liou, Deanna ; Marambaud, Philippe ; Wang, Ping</creatorcontrib><description>Background and Objectives AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics. Methods Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting. Results Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C. Conclusions Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.</description><identifier>ISSN: 0022-4790</identifier><identifier>EISSN: 1096-9098</identifier><identifier>DOI: 10.1002/jso.23184</identifier><identifier>PMID: 22674626</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>AMP-Activated Protein Kinases - antagonists &amp; inhibitors ; AMPK ; apoptosis ; Apoptosis - drug effects ; autophagy ; Autophagy - drug effects ; Cell Cycle - drug effects ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; colorectal cancer ; Colorectal Neoplasms - drug therapy ; Colorectal Neoplasms - pathology ; compound C ; Humans ; Pyrazoles - pharmacology ; Pyrimidines - pharmacology ; Tumor Suppressor Protein p53 - analysis</subject><ispartof>Journal of surgical oncology, 2012-11, Vol.106 (6), p.680-688</ispartof><rights>Copyright © 2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</citedby><cites>FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22674626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Weng-Lang</creatorcontrib><creatorcontrib>Perillo, William</creatorcontrib><creatorcontrib>Liou, Deanna</creatorcontrib><creatorcontrib>Marambaud, Philippe</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</title><title>Journal of surgical oncology</title><addtitle>J. Surg. Oncol</addtitle><description>Background and Objectives AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics. Methods Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting. Results Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C. Conclusions Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.</description><subject>AMP-Activated Protein Kinases - antagonists &amp; inhibitors</subject><subject>AMPK</subject><subject>apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>autophagy</subject><subject>Autophagy - drug effects</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>colorectal cancer</subject><subject>Colorectal Neoplasms - drug therapy</subject><subject>Colorectal Neoplasms - pathology</subject><subject>compound C</subject><subject>Humans</subject><subject>Pyrazoles - pharmacology</subject><subject>Pyrimidines - pharmacology</subject><subject>Tumor Suppressor Protein p53 - analysis</subject><issn>0022-4790</issn><issn>1096-9098</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kUFv0zAYhi0EYmVw4A8gS1zGIdtnO7Hj41SxDugYCBBHy3Vs6pLEwU609cZPx223HZB2-mR9z_vos16EXhM4JQD0bJPCKWWkLp-gGQHJCwmyfopmeUeLUkg4Qi9S2gCAlLx8jo4o5aLklM_Q3_OrL5-w79d-5ccQsQndEKa-wXOcpmGINiWbsLFti4cYWu9s1KMPPV5tc6qZzP4RHNZDGMaQfMI6p_U0hmGtf-0gvJ463WdzG6I1o26x0b2xcW9NL9Ezp9tkX93NY_Tj4v33-WWxvF58mJ8vC8MkKQsnDC1rTWqnOa0bTkzpHOiGSFpZ5ogg1q6McU4DB1tCXToKgtuKAdRVA-wYnRy8-Rt_JptG1fm0u0D3NkxJEUKYrIFXO_Ttf-gmTLHP1ylSVVSAJBXL1LsDZWJIKVqnhug7HbeKgNrVonItal9LZt_cGadVZ5sH8r6HDJwdgBvf2u3jJvXx2_W9sjgkfBrt7UNCx9-KCyYq9fPzQi0vxUKwr1Qt2T8I06c0</recordid><startdate>20121101</startdate><enddate>20121101</enddate><creator>Yang, Weng-Lang</creator><creator>Perillo, William</creator><creator>Liou, Deanna</creator><creator>Marambaud, Philippe</creator><creator>Wang, Ping</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20121101</creationdate><title>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</title><author>Yang, Weng-Lang ; Perillo, William ; Liou, Deanna ; Marambaud, Philippe ; Wang, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>AMP-Activated Protein Kinases - antagonists &amp; inhibitors</topic><topic>AMPK</topic><topic>apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>autophagy</topic><topic>Autophagy - drug effects</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>colorectal cancer</topic><topic>Colorectal Neoplasms - drug therapy</topic><topic>Colorectal Neoplasms - pathology</topic><topic>compound C</topic><topic>Humans</topic><topic>Pyrazoles - pharmacology</topic><topic>Pyrimidines - pharmacology</topic><topic>Tumor Suppressor Protein p53 - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Weng-Lang</creatorcontrib><creatorcontrib>Perillo, William</creatorcontrib><creatorcontrib>Liou, Deanna</creatorcontrib><creatorcontrib>Marambaud, Philippe</creatorcontrib><creatorcontrib>Wang, Ping</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Weng-Lang</au><au>Perillo, William</au><au>Liou, Deanna</au><au>Marambaud, Philippe</au><au>Wang, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells</atitle><jtitle>Journal of surgical oncology</jtitle><addtitle>J. Surg. Oncol</addtitle><date>2012-11-01</date><risdate>2012</risdate><volume>106</volume><issue>6</issue><spage>680</spage><epage>688</epage><pages>680-688</pages><issn>0022-4790</issn><eissn>1096-9098</eissn><abstract>Background and Objectives AMP‐activated protein kinase (AMPK) is a main regulator of energy metabolism through the inhibition of biosynthetic pathways and enhancement of ATP‐generating pathways. However, targeting AMPK as anti‐tumor therapy remains controversial. In this study, we examined the effect of compound C, a small molecule inhibitor of AMPK, on the proliferation of several human colorectal cancer cell lines with diverse characteristics. Methods Four human colorectal cancer cell lines (HCT116, DLD‐1, SW480, and KM12C) were treated with compound C. Cell viability was determined by MTS assay. Cell cycle prolife was analyzed by flow cytometry. Acidic vesicular organelles were detected by acridine orange staining. Protein levels were measured by western blotting. Results Compound C inhibited the growth of four cell lines in a dose‐dependent manner and caused G2/M arrest. Compound C increased sub‐G1 cell population and induced chromatin condensation and cleavage of PARP in HCT116 and KM12C cells, while it induced acidic vesicular formation and conversion of LC3‐I to autophagosome‐associated LC3‐II in DLD‐1 and SW480 cells. Survivin, an anti‐apoptotic protein, was down‐regulated in all cell lines treated with compound C. Conclusions Compound C induces apoptotic or autophagic death in colorectal cancer cells and the preferred death mode is cell type‐dependent. J. Surg. Oncol. 2012; 106:680–688. © 2012 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22674626</pmid><doi>10.1002/jso.23184</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-4790
ispartof Journal of surgical oncology, 2012-11, Vol.106 (6), p.680-688
issn 0022-4790
1096-9098
language eng
recordid cdi_proquest_miscellaneous_1113980650
source Wiley-Blackwell Read & Publish Collection
subjects AMP-Activated Protein Kinases - antagonists & inhibitors
AMPK
apoptosis
Apoptosis - drug effects
autophagy
Autophagy - drug effects
Cell Cycle - drug effects
Cell Line, Tumor
Cell Proliferation - drug effects
Cell Survival - drug effects
colorectal cancer
Colorectal Neoplasms - drug therapy
Colorectal Neoplasms - pathology
compound C
Humans
Pyrazoles - pharmacology
Pyrimidines - pharmacology
Tumor Suppressor Protein p53 - analysis
title AMPK inhibitor compound C suppresses cell proliferation by induction of apoptosis and autophagy in human colorectal cancer cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A36%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AMPK%20inhibitor%20compound%20C%20suppresses%20cell%20proliferation%20by%20induction%20of%20apoptosis%20and%20autophagy%20in%20human%20colorectal%20cancer%20cells&rft.jtitle=Journal%20of%20surgical%20oncology&rft.au=Yang,%20Weng-Lang&rft.date=2012-11-01&rft.volume=106&rft.issue=6&rft.spage=680&rft.epage=688&rft.pages=680-688&rft.issn=0022-4790&rft.eissn=1096-9098&rft_id=info:doi/10.1002/jso.23184&rft_dat=%3Cproquest_cross%3E1113980650%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3914-f7c248a18fa628d61c4ff0ad1925e3f171eebccffa060e4084f2076e530085d03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1552709153&rft_id=info:pmid/22674626&rfr_iscdi=true